Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Poonam Nagpal, Mohamed R. Akl, Nehad M. Ayoub, Tatsunari Tomiyama, Tasheka Cousins, Betty Tai, Nicole Carroll, Themba Nyrenda, Pritish Bhattacharyya, Michael B. Harris, Andre Goy, Andrew Pecora, K. Stephen Suh
Published Aug 22, 2016 · Vol. 7, No. 41 · pp. 67551-67573
Theophilos Tzaridis, Till Milde, Kristian W. Pajtler, Sebastian Bender, David T. W. Jones, Simone Müller, Andrea Wittmann, Magdalena Schlotter, Andreas E. Kulozik, Peter Lichter, V. Peter Collins, Olaf Witt, Marcel Kool, Andrey Korshunov, Stefan M. Pfister, Hendrik Witt
Published Aug 20, 2016 · Vol. 7, No. 38 · pp. 61860-61873
Khalil Ahmed, Betsy T. Kren, Md. Joynal Abedin, Rachel I. Vogel, Daniel P. Shaughnessy, Lucas Nacusi, Vicci L. Korman, Yingming Li, Scott M. Dehm, Cheryl L. Zimmerman, Gloria A. Niehans, Gretchen M. Unger, Janeen H. Trembley
Published Aug 20, 2016 · Vol. 7, No. 38 · pp. 61789-61805